Research briefs

What the published evidence actually says

One brief per compound. Each one reads the primary literature, says how strong it is, and says plainly where it does not exist. We take no money from anyone who sells these compounds, which is why some of these briefs are unflattering.

Every brief opens free: the key findings, and five of the sources themselves, there to be opened and checked. Our grade for the human evidence, and the review that argues for it, are the member edition. Members are the only people paying us, and that is the whole point.

What is free and what is paid

Free, no card. The opening of every brief: the key findings, and five of the sources, there to be opened and checked. And the peptide tracker, where you keep your own record of what you took and when. You enter everything yourself. We never suggest an amount.

$5 a month, or $29 a year. Our grade for the human evidence on every compound, the full review on every brief, the gaps we found, the complete source list, and each new brief as it is published.

The findings and the sources sit on the free side deliberately. Every fact a brief rests on can be read and checked here for nothing. What a membership buys is our judgment on it: the grade, and the review that argues for the grade.

Nobody who sells peptides pays us anything, and nothing we earn changes what a brief says. Members are the only people who pay us.

See the membership

How to read these briefs